Skip to search formSkip to main contentSkip to account menu

decitabine

Known as: Deoxyazacytidine, 2'-deoxy-5-azacytidine, AzadC compound 
A cytidine antimetabolite analogue with potential antineoplastic activity. Decitabine incorporates into DNA and inhibits DNA methyltransferase… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Azacytidine and decitabine are approved for treatment of acute myeloid leukemias and myelodysplastic syndromes. While clinical… 
Highly Cited
2009
Highly Cited
2009
Esophageal squamous cell carcinomas (ESCCs) tend to have multiple primary lesions, and it is believed that they arise from… 
Highly Cited
2007
Highly Cited
2007
Innovative epigenetic therapeutics comprise histone deacetylase inhibitors (HDAC‐I) and demethylating agents (DA). It was… 
Highly Cited
2005
Highly Cited
2005
Deoxycytosine methylation within CpG islands of tumor suppressor genes plays a prominent role in the development and progression… 
Highly Cited
2004
Highly Cited
2004
Purpose: WWOX (WW domain containing oxidoreductase) is a tumor suppressor gene that maps to the common fragile site FRA16D. We… 
Highly Cited
2001
Highly Cited
2001
To identify CpG islands differentially methylated in pancreatic adenocarcinoma, we used methylated CpG island amplification (MCA… 
Highly Cited
2001
Highly Cited
2001
Aberrant methylation of CpG islands within promoter regions is associated with transcriptional inactivation of various tumor… 
Highly Cited
2001
Highly Cited
2001
We hypothesize that elevation of Nm23-H1 expression in micrometastatic breast cancer cells may inhibit their metastatic… 
Highly Cited
1998
Highly Cited
1998
In this work, we address the question of whether replicative senescence can be induced in immortal nontumorigenic human…